FERM domain-containing protein FRMD5 regulates cell motility via binding to integrin β5 subunit and ROCK1

FEBS Lett. 2014 Nov 28;588(23):4348-56. doi: 10.1016/j.febslet.2014.10.012. Epub 2014 Oct 18.

Abstract

FRMD5 is a novel FERM domain-containing protein depicted in tumor progression. However, the mechanisms underlying FRMD5 inhibition of cell migration is largely unknown. Here, we show that FRMD5 regulates cell migration by interacting with integrin β5 cytoplasmic tail and ROCK1 in human lung cancer cells. FRMD5 promotes cell-matrix adhesion and cell spreading on vitronectin, and thus inhibits cell migration. Furthermore, FRMD5 interacts with ROCK1 and inhibits its activation that leads to the inhibition of myosin light chain phosphorylation and the actin stress fiber formation. Taken together, these findings demonstrate that the putative tumor suppressive protein FRMD5 regulates tumor cell motility via a dual pathway involving FRMD5 binding to integrin β5 tail and to ROCK1.

Keywords: Cell migration; FRMD5; Integrin β5; ROCK1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Adhesion
  • Cell Line, Tumor
  • Cell Movement*
  • Cytoplasm / metabolism
  • Humans
  • Integrin beta Chains / chemistry*
  • Integrin beta Chains / metabolism*
  • Protein Binding
  • Protein Structure, Tertiary
  • Protein Subunits / metabolism*
  • Stress Fibers / metabolism
  • Tumor Suppressor Proteins / chemistry*
  • Tumor Suppressor Proteins / metabolism*
  • rho-Associated Kinases / metabolism*

Substances

  • FRMD5 protein, human
  • Integrin beta Chains
  • Protein Subunits
  • Tumor Suppressor Proteins
  • integrin beta5
  • ROCK1 protein, human
  • rho-Associated Kinases